MitrAssist has received ISO certification for the design and development of an implantable heart valve prostheses.
Current standard treatment for mitral valve regurgitation (MR), blood leakage or backflow into the atrium, is open heart surgery. MitrAssist's design preserves the ventricular dynamic mode of function and mechanism, known to be crucial for long term patient outcome. The company's mitral valve prosthesis is delivered with a minimally-invasive procedure via a small-diameter catheter, keeping the existing valve intact. With its design focused on natural mitral valve anatomy, the MitrAssist mitral valve prosthesis will enable faster transition to minimally-invasive procedures for mitral repair.